XT
IRD

XTX Topco’s Opus Genetics IRD Stock Holding History

XTX Topco’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76K Sell
16,704
-7,033
-30% -$24.3K ﹤0.01% 3193
2025
Q4 		$47.7K Sell
23,737
-28,020
-54% -$56.9K ﹤0.01% 2846
2025
Q3 		$85.4K Buy
51,757
+35,949
+227% +$44.7K ﹤0.01% 2062
2025
Q2 		$14.9K Buy
+15,808
New +$14.6K ﹤0.01% 2206
2025
Q1 		– Sell
-43,578
Closed -$51.9K – 3260
2024
Q4 		$51.9K Buy
43,578
+15,686
+56% +$18K ﹤0.01% 1887
2024
Q3 		$36.5K Buy
+27,892
New +$42.9K ﹤0.01% 1747
2023
Q3 		– Sell
-16,911
Closed -$73.4K – 2088
2023
Q2 		$73.4K Buy
+16,911
New +$80.3K 0.01% 1199

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

XTX Topco's IRD Position: Q1 2026 in Review

XTX Topco reduced its Opus Genetics (IRD) stake by 30% in Q1 2026, selling an estimated $24.3K and leaving 16,704 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

XTX Topco first reported a position in IRD in Q2 2023 and has held it in 7 quarters since. The position peaked at $85.4K in Q3 2025. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • XTX Topco held 16,704 shares of Opus Genetics worth $76K as of Q1 2026.
  • XTX Topco sold 7,033 Opus Genetics shares in Q1 2026, an estimated $24.3K.
  • Opus Genetics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3193 holding.
  • XTX Topco first reported a position in Opus Genetics in Q2 2023 and has held it in 7 quarters since.
  • XTX Topco's Opus Genetics position peaked at $85.4K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.